Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The adenylate cyclase (CyaA) of Bordetella pertussis is able to deliver CD8(+) T cell epitopes into the cytosol of CD11b(+) dendritic cells (DC) following its specific interaction with the alpha(M)beta(2) integrin (CD11b/CD18). This delivery results in intracellular processing and presentation by MHC class I molecules of the CD8(+) T cell epitopes inserted into CyaA. Indeed, we previously showed that CyaA toxins carrying a single cytotoxic T lymphocyte (CTL) epitope can induce efficient protective and therapeutic antitumor immunity in mice. With a view to elaborating cancer immunotherapy in humans using CyaA, we constructed two recombinant CyaA carrying HLA*0201-restricted melanoma epitopes. Here we show that these recombinant CyaA induce strong anti-melanoma CTL responses in HLA*0201 transgenic mice, even after a single i.v. immunization without adjuvant. These responses are long lasting, since they were also detected 5 months after the last injection. Finally, human DC treated with the recombinant CyaA were shown to process and present efficiently the melanoma epitopes to human CTL clones. Altogether, our results demonstrate that tumoral epitopes inserted into CyaA are efficiently processed and presented in association with human MHC molecules. These observations suggest that CyaA is capable of activating antitumoral CTL in humans and highlight the potential of CyaA for use in cancer immunotherapy.

Type

Journal article

Journal

Int Immunol

Publication Date

12/2003

Volume

15

Pages

1423 - 1430

Keywords

Adenylate Cyclase Toxin, Aluminum Hydroxide, Animals, Catalytic Domain, Cytotoxicity, Immunologic, Dendritic Cells, Dose-Response Relationship, Immunologic, Epitopes, T-Lymphocyte, H-2 Antigens, HLA-A Antigens, HLA-A2 Antigen, Histocompatibility Antigen H-2D, Humans, Immunization, Injections, Intraperitoneal, Injections, Intravenous, Interferon-gamma, Melanoma, Mice, Mice, Knockout, Mice, Transgenic, Monophenol Monooxygenase, N-Acetylglucosaminyltransferases, Peptides, Recombinant Fusion Proteins, Spleen, T-Lymphocytes, Cytotoxic, beta 2-Microglobulin